The Company received Mandatory Tender Offer to acquire ordinary shares

Moscow, June 22, 2016
PJSC Pharmstandard (LSE: PHST IL, МОЕХ: PHST RU) (hereinafter the 'Company' or 'Pharmstandard') announces the receipt of a mandatory tender offer to acquire ordinary shares of the Company.
On June 22, 2016 the Company received from Augment Investments Limited, its controlling shareholder, a Russian law governed mandatory tender offer (the 'Offer')to acquire for cash ordinary shares of the Company from the remaining shareholders at a purchase price of RUB 1,028 per ordinary share.

The Offer is made in accordance with Article 84.2 of the Federal Law of the Russian Federation № 208-FZ On Joint Stock Companies due to the fact that Augment Investments Limited together with its affiliate, OJSC Pharmstandard-Leksredstva, controls 86,11% of ordinary shares of the Company.

The Board of Directors meeting to review the Offer is scheduled for June 27, 2016.

22.06.2016

JSC Pharmstandard published this content on 22 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 22 June 2016 16:15:02 UTC.

Original documenthttp://pharmstd.com/archivedetails_4_641.html

Public permalinkhttp://www.publicnow.com/view/EB8C306E47A64BC5336DDA5736D4437CE1B475D6